Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06436183
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-04-09
Brief Title:
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Sponsor:
Apollo Therapeutics Ltd
Organization:
Apollo Therapeutics Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-09
First Submit QC Date:
May 22 2024
Study First Post Date:
2024-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-02
Last Update Post Date:
2024-05-30
Last Update Post Date Type:
ACTUAL